Taurine

—

evidence score

amino acid

2-aminoethanesulfonic acidtau

Taurine is a sulfur-containing amino acid abundant in heart, skeletal muscle, retina, and brain. It is conditionally essential — synthesized endogenously but dietary intake meaningfully raises tissue levels. Evidence supports cardiovascular protection (reduces blood pressure, oxidative stress), endurance performance, electrolyte balance, and mitochondrial function. A 2023 Cell paper identified taurine decline as a hallmark of aging and showed supplementation extended lifespan in mice and improved health markers in primates.

Evidence

No score yet

Safety

Unknown safety profile

Clinical Status

No formal phase listed

Research Sync

Not synced yet

Dosing

Typical

2000 mg

500 mgRange6000 mg

Frequency1-3x/day

Set height & weight in Settings to see your dose.

Pharmacology

Half-life~1.5 hours (plasma); tissue half-life days to weeks

OnsetAcute hemodynamic effects within 1-2 hours; performance effects 1-2 weeks

DurationTissue stores maintained with daily dosing

Routes

oral

Evidence Score

—

0 studies indexed

Scoring Factors

Volume(40%)—

Quality(30%)—

Sample Size(10%)—

Consistency(10%)—

Replication(5%)—

Recency(5%)—

Evidence Levels

AScore ≥75 with at least 1 meta-analysis and 3+ RCTs

BScore ≥50 with at least 1 RCT or meta-analysis

CScore ≥25 — observational or animal evidence only

DScore <25 — very limited or preclinical data

Plain-English Snapshot

Taurine is currently categorized as a amino acid compound.

Evidence scoring has not been fully computed yet, so interpret this profile as preliminary.

Safety scoring is incomplete. Start conservatively and monitor carefully.

Core mechanism

Osmoregulation, membrane stabilization, mitochondrial quality control, GABA-A modulation, antioxidant via bile salt conjugation

Practical Context

Strongest current signals

No indexed study summaries yet.